Associations Between Physical Activity and Sedentary Behavior Profiles and Carotid Intima-media Thickness in Adolescents With Obesity (CARADO)
2. september 2026 oppdatert av: University of Avignon
Physical activity behaviors are key and modifiable factors of cardiovascular health from childhood. They encompass both physical activity, defined as any bodily movement produced by skeletal muscles that results in energy expenditure, and sedentary behavior, characterized by low energy expenditure while awake. Studying these behaviors in their diversity, beyond a simple active-inactive opposition, allows for a better understanding of their effects on health.
In adolescents, high levels of sedentary behavior and low levels of physical activity are both associated with an increased risk of overweight or obesity. Current recommendations advocate for at least 60 minutes of moderate-to-vigorous physical activity per day and the reduction of sedentary time. However, more than 80% of French adolescents do not meet these recommendations, a trend that is even more pronounced and problematic among those living with obesity.
Pediatric obesity is associated with early alterations in vascular health. Carotid intima-media thickness (cIMT), measured by ultrasound, is a recognized biomarker of future cardiovascular risk. Several studies have shown that sustained physical activity is associated with lower cIMT and better endothelial function, independently of body size. However, the methodological limitations of current studies, and the lack of data specific to adolescents with obesity, highlight the need for further research.
This project aims to better understand, in adolescents with obesity, the associations between physical activity and sedentary behavior profiles and physical fitness, on the one hand, and structural parameters, particularly cIMT, and vascular functional parameters known for their value as subclinical biomarkers of cardiovascular risk, on the other hand.
Studieoversikt
Status
Rekruttering
Forhold
Studietype
Observasjonsmessig
Registrering (Antatt)
108
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Agnès Vinet
- Telefonnummer: +33 4 13 95 13 44
- E-post: agnes.vinet@univ-avignon.fr
Studiesteder
-
-
-
Palavas-les-Flots, Frankrike, 34250
- Rekruttering
- Institut Saint Pierre
-
Ta kontakt med:
- Delphine Masson
- Telefonnummer: +33467077500
- E-post: GAY.C@institut-st-pierre.fr
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
Tar imot friske frivillige
Nei
Prøvetakingsmetode
Sannsynlighetsprøve
Studiepopulasjon
Adolescents were recruited from the specialized pediatric obesity center (COPS) at the Institut Saint-Pierre (Palavas les Flots, 34)
Beskrivelse
Inclusion Criteria:
- The parent(s) or legal guardian(s) must have provided parental consent, and the adolescent must have provided their assent.
- The adolescent must be affiliated with or covered by a health insurance scheme.
- The adolescent must be aged between 11 and 18 years.
- The participant must have a Body Mass Index (BMI) Z-score corresponding to obesity (reference: Rolland-Cachera et al., 1991 growth charts).
Exclusion Criteria:
- The adolescent has a contraindication to physical activity (joint, cardiac, or other).
- The adolescent is participating in another study.
- The adolescent is within an exclusion period determined by a previous study.
- The parent(s) or legal guardian(s) or the adolescent refuses to sign the parental consent or assent form, respectively.
- It is not possible to provide the adolescent or the parent(s) or legal guardian(s) with the required information for informed consent.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Carotid Intima Media Thickness
Tidsramme: During the single assessment visit
|
Measured by echography (Mylab, Esaote, Italy) and off-line analyses by CardioVascularSuite, measure in mm
|
During the single assessment visit
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Anthropometry
Tidsramme: At the inclusion (single assessment visit )
|
Height (cm), body mass (kg) used to calcultate the body mass index (BMI in kg/m² and z-score) as body mass/height*height.
Body composition is assessed using bioelectrical impedance analysis (BIA) mBCA SECA.
Fat mass, fat-free and muscle mass are measured in kg, reported to the body mass in %.
Waist and neck circumference measured by a tape measure.
|
At the inclusion (single assessment visit )
|
|
Tanner Stage
Tidsramme: At the inclusion (single assessment visit)
|
A clinical assessment performed by a medical doctor to determine the stage of pubertal development based on the development of secondary sexual characteristics.
Pubertal development is classified into five stages, ranging from stage I (prepubertal) to stage V (full maturation).
|
At the inclusion (single assessment visit)
|
|
Physical activity and sedentary behaviors
Tidsramme: Before incusion (single assessment visit)
|
Measured by accelerometric data using AX3 Axivity over 7-day consecutive period before inclusion
|
Before incusion (single assessment visit)
|
|
Aerobic fitness
Tidsramme: At inclusion (the single assessment visit)
|
Measured by the Spartacus 15-15 test, a progressive intermittent maximal running field test with prediction of VO2 max (Fillon et al., 2020) For girls: VO2max = last stage * 153.4433 + BMI * 58.64534 + age * -2.701522-921.2878
For boys: VO2max = last stage * 153.4433 + 320.1583 + BMI * 58.64534 + age * -2.701522-921.2878
|
At inclusion (the single assessment visit)
|
|
Maximal Heart Rate
Tidsramme: During the aerobic fitness test
|
Measured by a heart rate monitor (Polar Pacer 5A)
|
During the aerobic fitness test
|
|
Perceived Exertion
Tidsramme: During the aerobic fitness test
|
Assessed by 1 to 10 Borg's scale
|
During the aerobic fitness test
|
|
Extra media Thickness
Tidsramme: At the inclusion (single assessment visit)
|
Measured by echocardiography (Mylab, Esaote, Italie) and off-line analyses by CAROLAB, in mm
|
At the inclusion (single assessment visit)
|
|
Arterial diameter
Tidsramme: At the inclusion (single assessment visit)
|
Measured by ultrasound imaging (Mylab, Esaote, Italie) and off-line analyses by Cardiovascular Suite.
Measurements were expressed in millimeters (mm).
|
At the inclusion (single assessment visit)
|
|
Diastolic and systolic blood pressure, pulse pressure
Tidsramme: At the inclusion (single assessment visit)
|
Measured two times at rest on the left arm by an automated system Omron
|
At the inclusion (single assessment visit)
|
|
Carotid arterial compliance
Tidsramme: At inclusion (single assessment visit), calculated from measurements obtained during this visit
|
Assessed by ultrasound using carotid artery diameter and blood pressure measurements.
Compliance is calculated from the change in arterial diameter in response to pulse pressure.
|
At inclusion (single assessment visit), calculated from measurements obtained during this visit
|
|
TFEQ-21 questionnaire
Tidsramme: at the inclusion (single assessment visit)
|
Three-Factor Eating Questionnaire.
A 21-item self-report questionnaire used to assess three dimensions of eating behavior: cognitive restraint, uncontrolled eating, and emotional eating.
Each dimension is scored separately, with higher scores indicating a greater tendency toward the corresponding eating behavior.
|
at the inclusion (single assessment visit)
|
|
CAPAS-Q questionnaire
Tidsramme: At the inclusion (single assessment visit)
|
Children and Adolescents Physical Activity en Sedentary Questionnaire.
A self-administered questionnaire designed to assess physical activity and sedentary behaviors in children and adolescents.
It evaluates the frequency and duration of physical activities performed at different intensities, as well as sedentary behaviors, providing an assessment of the participant's usual physical activity and sedentary behavior patterns (Fillon et al., 2022)
|
At the inclusion (single assessment visit)
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Samarbeidspartnere
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Generelle publikasjoner
- Fillon A, Pereira B, Vanhelst J, Baran J, Masurier J, Guirado T, Boirie Y, Duclos M, Julian V, Thivel D. Development of the Children and Adolescents Physical Activity and Sedentary Questionnaire (CAPAS-Q): Psychometric Validity and Clinical Interpretation. Int J Environ Res Public Health. 2022 Oct 23;19(21):13782. doi: 10.3390/ijerph192113782.
- Phillips LR, Parfitt G, Rowlands AV. Calibration of the GENEA accelerometer for assessment of physical activity intensity in children. J Sci Med Sport. 2013 Mar;16(2):124-8. doi: 10.1016/j.jsams.2012.05.013. Epub 2012 Jul 6.
- Fillon A, Miguet M, O'Malley G, Mathieu ME, Masurier J, Julian V, Cardenoux C, Pereira B, Rey O, Duclos M, Boirie Y, Thivel D. Is the SPARTACUS 15-15 test an accurate proxy for the assessment and tracking of maximal aerobic capacities in adolescents with obesity? J Phys Ther Sci. 2020 Apr;32(4):281-287. doi: 10.1589/jpts.32.281. Epub 2020 Apr 2.
- Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. Body Mass Index variations: centiles from birth to 87 years. Eur J Clin Nutr. 1991 Jan;45(1):13-21.
- Willeit P, Tschiderer L, Allara E, Reuber K, Seekircher L, Gao L, Liao X, Lonn E, Gerstein HC, Yusuf S, Brouwers FP, Asselbergs FW, van Gilst W, Anderssen SA, Grobbee DE, Kastelein JJP, Visseren FLJ, Ntaios G, Hatzitolios AI, Savopoulos C, Nieuwkerk PT, Stroes E, Walters M, Higgins P, Dawson J, Gresele P, Guglielmini G, Migliacci R, Ezhov M, Safarova M, Balakhonova T, Sato E, Amaha M, Nakamura T, Kapellas K, Jamieson LM, Skilton M, Blumenthal JA, Hinderliter A, Sherwood A, Smith PJ, van Agtmael MA, Reiss P, van Vonderen MGA, Kiechl S, Klingenschmid G, Sitzer M, Stehouwer CDA, Uthoff H, Zou ZY, Cunha AR, Neves MF, Witham MD, Park HW, Lee MS, Bae JH, Bernal E, Wachtell K, Kjeldsen SE, Olsen MH, Preiss D, Sattar N, Beishuizen E, Huisman MV, Espeland MA, Schmidt C, Agewall S, Ok E, Asci G, de Groot E, Grooteman MPC, Blankestijn PJ, Bots ML, Sweeting MJ, Thompson SG, Lorenz MW; PROG-IMT and the Proof-ATHERO Study Groups. Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients. Circulation. 2020 Aug 18;142(7):621-642. doi: 10.1161/CIRCULATIONAHA.120.046361. Epub 2020 Jun 17.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
9. september 2024
Primær fullføring (Antatt)
1. mars 2027
Studiet fullført (Antatt)
1. september 2027
Datoer for studieregistrering
Først innsendt
2. september 2026
Først innsendt som oppfylte QC-kriteriene
2. september 2026
Først lagt ut (Faktiske)
9. september 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
9. september 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
2. september 2026
Sist bekreftet
1. september 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Ernæringsforstyrrelser
- Overernæring
- Kroppsvekt
- Overvektig
- Patologiske tilstander, tegn og symptomer
- Oppførsel
- Ernæringsmessige og metabolske sykdommer
- Tegn og symptomer
- Behandlingsoverholdelse og etterlevelse
- Helseatferd
- Pasientens aksept av helsehjelp
- Overvekt
- Motorisk aktivitet
- Stillesittende atferd
- Pasientens etterlevelse
Andre studie-ID-numre
- AU_ISP1_2026
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .